ENDV · Endonovo Therapeutics, Inc. · Insider Trading
$0.00
At close · Sep 16
Going-concern doubt
— flagged Dec 29, 2023
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt as to its ability to continue as going concern within one year from issuance date of these unaudited consolidated financial statements.”View the 10-Q filed Dec 29, 2023
Market Cap
$31,875
Shares
318.75M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2020-07-01 | Collier Alan Brian |
CEO |
Buy↑
|
Common Stock
|
100 |
| 2020-07-01 | Collier Alan Brian |
CEO |
Buy↑
|
Common Stock
|
100 |
| 2020-06-30 | Collier Alan Brian |
CEO |
Buy↑
|
Common Stock
|
200 |
| 2020-02-22 | Collier Alan Brian |
CEO |
Buy↑
|
Common Stock
|
100 |
| 2020-01-02 | Collier Alan Brian |
CEO |
Buy↑
|
Common Stock
|
100 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–5 of 5 transactions